CINECA IRIS Institutional Research Information System

SAPINO, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.836
EU - Europa 12.550
AS - Asia 8.689
SA - Sud America 758
AF - Africa 201
OC - Oceania 184
Continente sconosciuto - Info sul continente non disponibili 20
Totale 42.238
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.413
CN - Cina 3.965
IT - Italia 3.315
SG - Singapore 2.303
IE - Irlanda 1.403
DE - Germania 1.295
SE - Svezia 1.157
FR - Francia 956
GB - Regno Unito 858
FI - Finlandia 773
UA - Ucraina 754
BR - Brasile 615
KR - Corea 516
AT - Austria 483
PL - Polonia 444
VN - Vietnam 387
CA - Canada 351
JP - Giappone 334
IN - India 300
HK - Hong Kong 218
ES - Italia 209
NL - Olanda 204
AU - Australia 175
ID - Indonesia 172
BE - Belgio 117
TR - Turchia 116
DK - Danimarca 106
RU - Federazione Russa 83
TW - Taiwan 77
CH - Svizzera 74
SN - Senegal 74
TH - Thailandia 56
MX - Messico 55
RO - Romania 49
IR - Iran 44
PT - Portogallo 41
IL - Israele 38
GR - Grecia 37
CZ - Repubblica Ceca 34
AR - Argentina 33
UZ - Uzbekistan 32
CO - Colombia 30
HU - Ungheria 30
NO - Norvegia 30
EG - Egitto 27
CL - Cile 21
NG - Nigeria 21
PE - Perù 21
SA - Arabia Saudita 19
EC - Ecuador 15
IQ - Iraq 15
ZA - Sudafrica 14
EU - Europa 13
MA - Marocco 13
TN - Tunisia 13
PK - Pakistan 12
VE - Venezuela 12
BD - Bangladesh 11
MK - Macedonia 11
PH - Filippine 11
BA - Bosnia-Erzegovina 10
BG - Bulgaria 9
MY - Malesia 9
NZ - Nuova Zelanda 9
HR - Croazia 8
MU - Mauritius 8
SI - Slovenia 8
AE - Emirati Arabi Uniti 7
BY - Bielorussia 7
CR - Costa Rica 7
LT - Lituania 7
QA - Qatar 7
RS - Serbia 7
SK - Slovacchia (Repubblica Slovacca) 7
EE - Estonia 6
KE - Kenya 6
MO - Macao, regione amministrativa speciale della Cina 6
AM - Armenia 5
JO - Giordania 5
KW - Kuwait 5
LV - Lettonia 5
PY - Paraguay 5
SD - Sudan 5
AP - ???statistics.table.value.countryCode.AP??? 4
AZ - Azerbaigian 4
CI - Costa d'Avorio 4
NP - Nepal 4
A1 - Anonimo 3
AL - Albania 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
GH - Ghana 3
HN - Honduras 3
MD - Moldavia 3
TG - Togo 3
UY - Uruguay 3
BF - Burkina Faso 2
BH - Bahrain 2
DZ - Algeria 2
IS - Islanda 2
Totale 42.214
Salva come PNG Salva come JPEG
Città #
Chandler 2.056
Beijing 1.772
Dublin 1.342
Fairfield 1.290
Singapore 1.258
Santa Clara 1.173
Ann Arbor 1.144
Houston 1.078
Ashburn 891
Woodbridge 660
Torino 647
Dearborn 595
Wilmington 560
Jacksonville 553
Seattle 513
Villeurbanne 493
Medford 464
Vienna 432
Cambridge 425
Princeton 412
Nyköping 396
Columbus 369
Warsaw 365
Pisa 313
Turin 292
Milan 261
Redwood City 250
Dong Ket 219
Shanghai 200
Guangzhou 198
Jakarta 162
Menlo Park 152
Toronto 147
Nanjing 145
Fremont 141
Hong Kong 139
Boston 134
Helsinki 129
New York 128
Boardman 125
Hangzhou 124
Hefei 100
San Diego 94
Munich 93
Verona 86
Tokyo 84
Nuremberg 82
London 81
Rome 79
Chengdu 71
São Paulo 69
Brussels 66
Norwalk 65
Pune 62
Jinan 60
Silver Spring 60
Wuhan 60
The Dalles 58
Washington 58
Los Angeles 57
Phoenix 56
Kunming 54
Chicago 49
Zhengzhou 49
Falls Church 44
Düsseldorf 43
Lachine 41
Taipei 41
Fuzhou 40
Nanchang 37
Changsha 36
Seoul 36
Mountain View 35
Amsterdam 34
Chongqing 33
Lappeenranta 33
Tappahannock 32
Upper Marlboro 32
Paris 31
Shenyang 31
Sydney 31
Xian 30
Falkenstein 29
Ottawa 28
Bologna 27
Rio de Janeiro 27
Dallas 26
Genoa 26
Hebei 26
Bangkok 25
Berlin 25
Naples 25
Nürnberg 25
Tianjin 25
Istanbul 23
Madrid 23
Barcelona 22
Florence 22
Moncalieri 22
Mumbai 22
Totale 24.828
Salva come PNG Salva come JPEG
Nome #
PARP Inhibitors in Ovarian Cancer 2.787
A molecularly annotated platform of patient-derived xenografts (‘xenopatients’) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer 754
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer 707
Beneficial behavioural effects of IBD therapy and gluten/casein-free diet in an Italian cohort of patients with autistic enterocolitis followed over one year 661
Autistic enterocolitis: confirmation of a new inflammatory bowel disease in an Italian cohort of patients 500
Distribution pattern of the Ki67 labelling index in breast cancer and its implications for choosing cut-off values 372
MammaPrint Molecular Diagnostics on Formalin-Fixed, Paraffin-Embedded Tissue 345
Cytokine Induced Killer cells kill chemo-surviving melanoma cancer stem cells 333
Reliability of Whole Sentinel Lymph Node Analysis by One-Step Nucleic Acid Amplification for Intraoperative Diagnosis of Breast Cancer Metastases 324
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts 308
Personalized therapeutic strategies in HER2-driven gastric cancer 297
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries 291
Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis. 275
Abstract P6-08-12: DSCAM-AS1, a breast cancer specific and Estrogen receptor α-dependent long noncoding RNA, is a key component of the pathway controlling cell growth and migration 274
Acid-free glyoxal as a substitute of formalin for structural and molecular preservation in tissue samples 273
Proteomic identification of Reticulocalbin 1 as potential tumor marker in renal cell carcinoma. 270
Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy. 264
Comparison of Anti-Estrogen Receptor Antibodies SP1, 6F11, and 1D5 in Breast Cancer: Lower 1D5 Sensitivity but Questionable Clinical Implications 262
A "Weighted" Fluorescence In Situ Hybridization Strengthens the Favorable Prognostic Value of 1p/19q Codeletion in Pure and Mixed Oligodendroglial Tumors. 248
A comprehensive PDX gastric cancer collection captures cancer cell intrinsic transcriptional MSI traits 247
Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma 242
A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer 239
Primary systemic treatment and concomitant low dose radiotherapy for breast cancer: Final results of a prospective phase II study 236
SF3B1mutations constitute a novel therapeutic target in breast cancer 234
Sentinel Lymph Node Biopsy in Thick-Melanoma Patients (N=350): What is Its Prognostic Role? 228
Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up 222
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast 220
The diagnosis of inflammatory bowel disease is often unsupported in clinical practice 217
The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling 217
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives 217
Androgen receptor status predicts development of brain metastases in ovarian cancers 214
High USP6NL levels in breast cancer sustain chronic AKT phosphorylation and GLUT1 stability fueling aerobic glycolysis 211
High-throughput molecular analysis from leftover of fine needle aspiration cytology of mammographically detected breast cancer. 208
Oxytocin synthesis within the normal and neoplastic breast: first evidence of a local peptide source 206
Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond 199
HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast 198
THE EXPRESSION OF LINE1-MET CHIMERIC TRANSCRIPT IDENTIFIES A SUBGROUP OF AGGRESSIVE BREAST CANCERS 198
The expression of growth hormone releasing hormone (GHRH) and its receptors in breast carcinomas with apocrine differentiation - further evidence of the presence of a GHRH pathway in these tumors 197
Differences and homologies of chromosomal alterations within and between breast cancer cell lines: a clustering analysis 193
miR-221/222 control luminal breast cancer tumor progression by regulating different targets 191
Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases 191
Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro 190
FOXA1 and AR in invasive breast cancer: New findings on their co-expression and impact on prognosis in ER-positive patients 188
Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas 187
The influence of tissue ischemia time on RNA integrity and patient-derived xenografts (PDX) engraftment rate in a non-small cell lung cancer (NSCLC) Biobank 187
Effect of low doses of estradiol and tamoxifen on breast cancer cell karyotypes 183
Relevance of multiple basin drainage and primary histologic regression in prognosis of trunk melanoma patients with negative sentinel lymph nodes. 180
Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer 178
Critical roles of specimen type and temperature before and during fixation in the detection of phosphoproteins in breast cancer tissues 176
Are Breast Cancer Molecular Classes Predictive of Survival in Patients with Long Follow-Up? 172
Spontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell lines. 171
Current Challenges for HER2 Testing in Diagnostic Pathology: State of the Art and Controversial Issues 168
Tamoxifen treatment of breast cancer cells: Impact on Hedgehog/GLI1 signaling 168
Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition 167
Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function 166
Meningeal carcinomatosis underdiagnosis and overestimation: Incidence in a large consecutive and unselected population of breast cancer patients 164
A collection of primary tissue cultures of tumors from vacuum packed and cooled surgical specimens: a feasibility study 163
The impact of malignant nipple discharge cytology (NDc) in surgical management of breast cancer patients 161
The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment 161
Unraveling the chromosome 17 patterns of FISH in interphase nuclei: an in-depth analysis of the HER2 amplicon and chromosome 17 centromere by karyotyping, FISH and M-FISH in breast cancer cells. 160
miR-205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling 160
A rare case of breast cancer showing distinct TTF-1 nuclear expression: small cell carcinoma or not? 160
Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy 159
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study 159
Glycerolized reticular dermis as a new human acellular dermal matrix: An exploratory study 156
Flexible Lab-Tailored Cut-Offs for Suitability of Formalin-Fixed Tumor Samples for Diagnostic Mutational Analyses 154
Colesterolo ossidato e induzione del recettore scavenger CD36 153
Improved Outcome Prediction for Appendiceal Pseudomyxoma Peritonei by Integration of Cancer Cell and Stromal Transcriptional Profiles 152
Pleomorphism of the Nuclear Envelope in breast cancer: a new approach to an old problem 147
Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study 147
A tissue quality index: an intrinsic control for measurement of effects of preanalytical variables on FFPE tissue 146
The perfect pathology report after neoadjuvant therapy 144
“To Be or Not to Be in a Good Shape”: Diagnostic and Clinical Value of Nuclear Shape Irregularities in Thyroid and Breast Cancer 143
Efficiency of a Preoperative Axillary Ultrasound and Fine-Needle Aspiration Cytology to Detect Patients with Extensive Axillary Lymph Node Involvement 143
Sviluppo pre-clinico di una nuova matrice dermica acellulare di derivazione umana per la ricostruzione mammaria post oncologica 140
Integration of Ki-67 index into AJCC 2018 staging provides additional prognostic information in breast tumours candidate for genomic profiling 139
CUTseq is a versatile method for preparing multiplexed DNA sequencing libraries from low-input samples 137
Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS gene 135
A simple and reproducible prognostic index in luminal ER-positive breast cancers. 135
DSCAM-AS1-Driven Proliferation of Breast Cancer Cells Involves Regulation of Alternative Exon Splicing and 3′-End Usage 134
Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report 134
Formalin fixation at low temperature better preserves nucleic acid integrity. 132
Association of Histologic Regression in Primary Melanoma With Sentinel Lymph Node Status: A Systematic Review and Meta-analysis 132
[Tumor samples as a tool for large-scale monitoring of antigen-specific lymphocytes in gastric and colorectal neoplasms] 132
ASPM and CITK regulate spindle orientation by affecting the dynamics of astral microtubules 131
Search for Neuro-Endocrine Markers (Chromogranin A, Synaptophysin and VGF) in Breast Cancers. An integrated Approach Using Immunohistochemistry and Gene Expression Profiling 130
Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort 130
International expert consensus on primary systemic therapy in the management of early breast cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013) 129
Epidermal Growth Factor Receptor Gene in Primary Tumor and Metastatic Sites from Non-small Cell Lung Cancer. J Thorac Oncol. 2009 Apr 29 128
Two new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations identified in a cohort of Italian breast and ovarian cancer families. 128
The role of the AR/ER ratio in ER-positive breast cancer patients 127
Sparsely-connected autoencoder (SCA) for single cell RNAseq data mining 127
Neutralization of IL-10 And TGF beta 1 rescues T cells from tolerogenic mechanisms induced by HER2 vaccine in cancer patients 126
Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: A single centre observational cohort study. 126
Tumor types derived from epithelial and myoepithelial cell lines of R3230AC rat mammary carcinoma. 125
Do Chromosome 17 Centromere Copy Numbers Predict Polysomy? A Fluorescence In Situ Hybridization and Microarray-Based CGH Analysis. 124
Towards a formalin-free hospital. Levels of 15-F2t-isoprostane and malondialdehyde to monitor exposure to formaldehyde in nurses from operating theatres 124
BRCA1/2 Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories 124
Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer. 122
Contrast enhanced ultrasound in atherosclerotic carotid artery disease. 121
Totale 23.055
Salva come PNG Salva come JPEG
Categoria #
all - tutte 129.653
article - articoli 0
book - libri 0
conference - conferenze 8.582
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.235
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020580 0 0 0 0 0 0 0 0 0 0 343 237
2020/20214.889 315 282 416 332 386 334 480 303 522 482 316 721
2021/20225.430 291 309 318 440 316 311 441 388 259 352 998 1.007
2022/20236.737 684 548 206 559 647 1.571 539 474 715 182 374 238
2023/20243.690 422 581 218 246 255 402 179 245 56 270 314 502
2024/20256.879 149 431 372 738 1.923 616 328 510 1.018 636 158 0
Totale 43.443